CTOs on the Move

Genetics and IVF Institute

www.givf.com

 
Genetics and IVF Institute is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Genetics and IVF Institute is based in Fairfax, VA. You can find more information on Genetics and IVF Institute at www.givf.com
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.givf.com
  • 3020 Javier Rd
    Fairfax, VA USA 22031
  • Phone: 703.698.7355

Executives

Name Title Contact Details

Similar Companies

Medical Management Strategies

Medical Management Strategies is a San Luis Obispo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Moorestown Visiting Nurse Association

Moorestown Visiting Nurse Association is a Moorestown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InterWell Health

Interwell Health is a kidney care management company that partners with physicians on its mission to reimagine healthcare – with the expertise, compassion, and vision to set the standard for the industry and help patients live their best lives. The company is differentiated by its ability to deliver improved clinical outcomes and better quality of life for patients, reduce the total cost of care for payer partners, and provide the resources physicians need to thrive in a value-based world – all at scale.

Charles T Sitrin Health Care

Charles T Sitrin Health Care is a New Hartford, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.